Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says – CNBC

1. Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says  CNBC
2. Experimental cancer vaccine, combined with immunotherapy, continues to show benefits against melanoma, trial shows  CNN
3. Moderna’s stock rallies 7.9% after announcing positive data in trial of melanoma treatment combined with Merck’s Keytruda  MarketWatch
4. Moderna (MRNA), Merck Start 2nd Late-Study on Cancer Therapy  Yahoo Finance
5. Merck-Moderna Vaccine Cuts Risk of Skin Cancer Returning by Half  Bloomberg

Source: Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says – CNBC